Efficacy of Physiotherapy on the Health and Quality of Life of the Rheumatic Patient
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02020668|
Recruitment Status : Unknown
Verified May 2014 by Macmillan Research Group UK.
Recruitment status was: Not yet recruiting
First Posted : December 25, 2013
Last Update Posted : May 7, 2014
Despite leading cause of morbidity, treatment strategies for Rheumatic diseases are geared almost exclusively toward medical-pharmacological area away from offering the patient the possibility of an interdisciplinary approach to their disease.
Present study test whether treatment of physiotherapy reduces stiffness and pain inherent in rheumatic disease and improve their quality of life related to health.
|Condition or disease||Intervention/treatment||Phase|
|Rheumatic Arthritis||Other: Physiotherapy Other: Wait list control||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||82 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Phase II Study of Physiotherapy in Rheumatoid Arthritis: Randomized Single Blind Wait-list Controlled Trial|
|Study Start Date :||May 2014|
|Estimated Primary Completion Date :||September 2014|
|Estimated Study Completion Date :||December 2014|
Physiotherapy included joint protection strategies, performance of therapeutic exercises and patient education.
Wait list control
Wait list control received standard care and were invited to join the physiotherapy once intervention period is finished.
Other: Wait list control
- Pain [ Time Frame: Change from baseline in Numerical Scale Downie at 16 weeks ]
- Quality of Life [ Time Frame: Change from Baseline in Short Form (SF) 36 at 16 weeks ]
- Functional capacity [ Time Frame: Change from baseline in Barthel Index at 16 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02020668
|Contact: Virendra Shekhawat, MAemail@example.com|
|Life Line Hospital|
|Sikar, Rajasthan, India|
|Contact: Deepika Ratan 9413623113|
|Study Director:||Neha Sharma, PhD||Macmillan Research Group|
|Principal Investigator:||Om Prakash Sharma, MBBS||Life Line Hospital, Sikar, India|